10.1007/s12672-024-01356-8 39 FineJ.KoncJ.SamudralaR.ChopraG
Tesamorelin FDA-approved for HIV-associated lipodystrophy, its used off-label to reduce abdominal fat and improve metabolic health
tuning the potency at GLP-1 receptor to achieve efficient and safe GLP-1 activity at doses compatible with strong PCSK9 suppression
Can I skip the lower doses and start at a higher dose
210.2 Individual and Community-Level Social Determinants Associated with Representation in a Cellular Therapy Registry Carlos Litovich 1 , Miranda Kapfhammer 1 , Sarah Thryselius 1 , Deborah Mattila 2 , Nick Feng 1 , Mehdi Hamadani 1 , Bronwen Shaw 1 , Jessica Olson 1 , David Nelson 1 , Rachel Cusatis 1 1 Medical College of Wisconsin, Milwaukee, Wisconsin, USA, 2 NMDP, Minneapolis, Minnesota, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :210.2 Aims Representation in national clinical and patient-reported outcome (PRO) registries is driven by both clinical and sociocultural factors
Medical eligibility extends beyond BMI criteria